Selected research
Market Structure
Global Famotidine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Famotidine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Famotidine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Famotidine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Famotidine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Famotidine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Famotidine include UQUIFA, Rakshit Drug, Phalanx Labs, PAT IMPEX, Jayusion, Gauri Fine Chemicals, Darou Pakhsh Pharma Chem and Chempro Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Famotidine output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Famotidine by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Famotidine market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Famotidine and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Famotidine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Famotidine market size, projected growth trends, production technologies, key applications, and end-use industries.
Famotidine Segment by Company
UQUIFA
Rakshit Drug
Phalanx Labs
PAT IMPEX
Jayusion
Gauri Fine Chemicals
Darou Pakhsh Pharma Chem
Chempro Pharma
Famotidine Segment by Type
Tablets
Injection
Famotidine Segment by Application
Hospital
Clinic
Other
Famotidine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Famotidine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Famotidine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Famotidine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Famotidine market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Famotidine industry.
Chapter 3: Detailed analysis of Famotidine market competition landscape. Including Famotidine manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Famotidine by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Famotidine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Injection
Applications
- Hospital
- Clinic
- Other
Companies covered
- UQUIFA
- Rakshit Drug
- Phalanx Labs
- PAT IMPEX
- Jayusion
- Gauri Fine Chemicals
- Darou Pakhsh Pharma Chem
- Chempro Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Famotidine Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Famotidine Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Famotidine Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Famotidine Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Famotidine Market Dynamics
- 2.1 Famotidine Industry Trends
- 2.2 Famotidine Industry Drivers
- 2.3 Famotidine Industry Opportunities and Challenges
- 2.4 Famotidine Industry Restraints
3 Famotidine Market by Manufacturers
- 3.1 Global Famotidine Production Value by Manufacturers (2021-2026)
- 3.2 Global Famotidine Production by Manufacturers (2021-2026)
- 3.3 Global Famotidine Average Price by Manufacturers (2021-2026)
- 3.4 Global Famotidine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Famotidine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Famotidine Manufacturers, Product Type & Application
- 3.7 Global Famotidine Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Famotidine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Famotidine Players Market Share by Production Value in 2025
- 3.8.3 2025 Famotidine Tier 1, Tier 2, and Tier 3
4 Famotidine Market by Type
- 4.1 Famotidine Type Introduction
- 4.1.1 Tablets
- 4.1.2 Injection
- 4.2 Global Famotidine Production by Type
- 4.2.1 Global Famotidine Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Famotidine Production by Type (2021-2032)
- 4.2.3 Global Famotidine Production Market Share by Type (2021-2032)
- 4.3 Global Famotidine Production Value by Type
- 4.3.1 Global Famotidine Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Famotidine Production Value by Type (2021-2032)
- 4.3.3 Global Famotidine Production Value Market Share by Type (2021-2032)
5 Famotidine Market by Application
- 5.1 Famotidine Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Famotidine Production by Application
- 5.2.1 Global Famotidine Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Famotidine Production by Application (2021-2032)
- 5.2.3 Global Famotidine Production Market Share by Application (2021-2032)
- 5.3 Global Famotidine Production Value by Application
- 5.3.1 Global Famotidine Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Famotidine Production Value by Application (2021-2032)
- 5.3.3 Global Famotidine Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 UQUIFA
- 6.1.1 UQUIFA Company Information
- 6.1.2 UQUIFA Business Overview
- 6.1.3 UQUIFA Famotidine Production, Value and Gross Margin (2021-2026)
- 6.1.4 UQUIFA Famotidine Product Portfolio
- 6.1.5 UQUIFA Recent Developments
- 6.2 Rakshit Drug
- 6.2.1 Rakshit Drug Company Information
- 6.2.2 Rakshit Drug Business Overview
- 6.2.3 Rakshit Drug Famotidine Production, Value and Gross Margin (2021-2026)
- 6.2.4 Rakshit Drug Famotidine Product Portfolio
- 6.2.5 Rakshit Drug Recent Developments
- 6.3 Phalanx Labs
- 6.3.1 Phalanx Labs Company Information
- 6.3.2 Phalanx Labs Business Overview
- 6.3.3 Phalanx Labs Famotidine Production, Value and Gross Margin (2021-2026)
- 6.3.4 Phalanx Labs Famotidine Product Portfolio
- 6.3.5 Phalanx Labs Recent Developments
- 6.4 PAT IMPEX
- 6.4.1 PAT IMPEX Company Information
- 6.4.2 PAT IMPEX Business Overview
- 6.4.3 PAT IMPEX Famotidine Production, Value and Gross Margin (2021-2026)
- 6.4.4 PAT IMPEX Famotidine Product Portfolio
- 6.4.5 PAT IMPEX Recent Developments
- 6.5 Jayusion
- 6.5.1 Jayusion Company Information
- 6.5.2 Jayusion Business Overview
- 6.5.3 Jayusion Famotidine Production, Value and Gross Margin (2021-2026)
- 6.5.4 Jayusion Famotidine Product Portfolio
- 6.5.5 Jayusion Recent Developments
- 6.6 Gauri Fine Chemicals
- 6.6.1 Gauri Fine Chemicals Company Information
- 6.6.2 Gauri Fine Chemicals Business Overview
- 6.6.3 Gauri Fine Chemicals Famotidine Production, Value and Gross Margin (2021-2026)
- 6.6.4 Gauri Fine Chemicals Famotidine Product Portfolio
- 6.6.5 Gauri Fine Chemicals Recent Developments
- 6.7 Darou Pakhsh Pharma Chem
- 6.7.1 Darou Pakhsh Pharma Chem Company Information
- 6.7.2 Darou Pakhsh Pharma Chem Business Overview
- 6.7.3 Darou Pakhsh Pharma Chem Famotidine Production, Value and Gross Margin (2021-2026)
- 6.7.4 Darou Pakhsh Pharma Chem Famotidine Product Portfolio
- 6.7.5 Darou Pakhsh Pharma Chem Recent Developments
- 6.8 Chempro Pharma
- 6.8.1 Chempro Pharma Company Information
- 6.8.2 Chempro Pharma Business Overview
- 6.8.3 Chempro Pharma Famotidine Production, Value and Gross Margin (2021-2026)
- 6.8.4 Chempro Pharma Famotidine Product Portfolio
- 6.8.5 Chempro Pharma Recent Developments
7 Global Famotidine Production by Region
- 7.1 Global Famotidine Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Famotidine Production by Region (2021-2032)
- 7.2.1 Global Famotidine Production by Region (2021-2026)
- 7.2.2 Global Famotidine Production Forecast by Region (2027-2032)
- 7.3 Global Famotidine Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Famotidine Production Value by Region (2021-2032)
- 7.4.1 Global Famotidine Production Value by Region (2021-2026)
- 7.4.2 Global Famotidine Production Value by Region (2027-2032)
- 7.5 Global Famotidine Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Famotidine Production Value (2021-2032)
- 7.6.2 Europe Famotidine Production Value (2021-2032)
- 7.6.3 Asia-Pacific Famotidine Production Value (2021-2032)
- 7.6.4 South America Famotidine Production Value (2021-2032)
- 7.6.5 Middle East & Africa Famotidine Production Value (2021-2032)
8 Global Famotidine Consumption by Region
- 8.1 Global Famotidine Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Famotidine Consumption by Region (2021-2032)
- 8.2.1 Global Famotidine Consumption by Region (2021-2026)
- 8.2.2 Global Famotidine Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Famotidine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Famotidine Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Famotidine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Famotidine Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Famotidine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Famotidine Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Famotidine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Famotidine Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Famotidine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Famotidine Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Famotidine Value Chain Analysis
- 9.1.1 Famotidine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Famotidine Production Mode & Process
- 9.2 Famotidine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Famotidine Distributors
- 9.2.3 Famotidine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst